Explore practical perspectives on Saudi Arabia’s biotechnology and life sciences ecosystem, including pharmaceutical R&D, SFDA and ICH regulatory frameworks, technology transfer, commercialization, manufacturing readiness and Vision 2030 innovation priorities.
How Vision 2030 and the National Biotechnology Strategy are shaping Saudi R&D, biomanufacturing, localization, technology transfer and life sciences investment.
How SFDA requirements, ICH CTD/eCTD principles and GxP controls connect research evidence with submission readiness and pharmaceutical lifecycle compliance.
A practical look at moving Saudi life sciences programs from research through development, manufacturing, technology transfer and commercialization.